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Abstract: 
The obligate intracellular bacterial pathogen Chlamydia trachomatis deploys 
virulence effectors to subvert host cell functions enabling its replication within a 
specialized membrane-bound compartment termed an inclusion. The control of 
the host cytoskeleton is critical for Chlamydia uptake, inclusion biogenesis and cell 
exit. Here we demonstrate how a Chlamydia effector rearranges the microtubule 
network by initiating organization of the microtubules at the inclusion surface. We 
identified an inclusion-localized effector sufficient to interfere with microtubule 
assembly that we term inclusion protein acting on microtubules (IPAM). We 
established that IPAM recruits and stimulates the centrosomal protein 170kDa 
(CEP170) to hijack the microtubule organizing functions of the host cell. We show 
that CEP170 is essential for chlamydial control of host microtubule assembly, and 
is required for inclusion morphogenesis and bacterial infectivity. Together, we 
demonstrate how a pathogen effector reprograms the host microtubule network 
to support its intracellular development. 
 
Introduction: 
Chlamydiae are obligate intracellular pathogens that remain the leading bacterial 
cause of sexually transmitted disease worldwide and blinding trachoma in 
developing nations. Increasing evidence also suggests that chlamydial infection may 
contribute to tumorigenic processes in cervical cancer (Smith et al., 2004; Koskela et 
al., 2000). 
Adherent chlamydial elementary bodies (EBs) employ a type III secretion system 
(T3SS) to deliver effectors that induce the reorganization of the actin cytoskeleton, 
promoting membrane deformation that triggers EB uptake into target cells. After 
internalization, individual EBs are encapsulated within vacuoles derived from the 
host plasma membrane. These vacuoles are rapidly diverted from the endocytic 
pathway and instead traffic to the perinuclear region, where they coalesce to form a 
larger specialized compartment termed the inclusion. In this environment, the 
bacteria differentiate into reticulate bodies (RBs) and actively replicate 
(Abdelrahman and Belland, 2005).  
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A family of hydrophobic T3SS effectors called inclusion proteins (Incs) localize to the 
boundary membrane of the inclusion. Incs are key mediators of Chlamydia-host 
interactions together with other effectors that are delivered into the host cytosol 
and nucleus (Peters et al., 2007). Although most effector activities remain 
uncharacterized, inclusion biogenesis and bacterial growth are dependent upon the 
recruitment of Golgi-derived vesicles (Carabeo et al., 2003), multivesicular bodies 
(Beatty, 2006), lipid droplets (Cocchiaro et al., 2008) and the rough endoplasmic 
reticulum (Dumoux et al., 2012).  
In addition to hijacking host organelles, Chlamydia also exploits the cytoskeleton to 
support its lifecycle. For instance, the T3SS effector Tarp is translocated during entry 
and promotes actin polymerization beneath the plasma membrane both directly and 
indirectly by stimulating the Arp2/3 complex (Jewett et al., 2006; Lane et al., 2008). 
An actin and intermediate filament cage is required for the integrity of mature 
inclusions (Kumar and Valdivia, 2008), and an acto-myosin-dependent process 
regulates inclusion extrusion from the infected cell (Hybiske and Stephens, 2007). 
Early Chlamydia-containing vacuoles utilize microtubules (MTs) to migrate from the 
cell periphery towards the MT-organizing centre (MTOC) (Richards et al., 2013). Src 
family kinases regulate the tight association of the nascent and later mature 
C.trachomatis inclusion with the centrosome (Richards et al., 2013; Mital et al., 
2010; Grieshaber et al., 2006), and disruption of this interaction forces the bacteria 
to enter into persistence (Romano et al., 2013; Leonhardt et al., 2007). Additionally, 
C.trachomatis induces centrosome supernumeracy by disrupting the centrosome 
duplication pathway (Johnson et al., 2009). MTs are also recruited in the vicinity of 
the chlamydial inclusion (Al-Younes et al., 2011), and MT-dependent transport 
processes sequester secretory traffic into the mature inclusion (Carabeo et al., 2003). 
However, how microtubule organization is initiated and controlled by C.trachomatis 
remains unknown. We hypothesized that a chlamydial Inc protein might be 
important to initialize MT organization at the inclusion surface. 
Here, we identified IPAM as an inclusion protein acting on MT. We demonstrated 
that ectopic expression of the predicted cytosol-exposed C-terminal domain of this 
Inc (IPAM-CTD) is sufficient to disturb the MT organizing activity of the cell. We used 
purified full-length IPAM in pull-down assays and identified the centrosomal protein 
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170kDa (CEP170) as a host target by mass spectrometry. IPAM-CTD was also 
sufficient for CEP170 interaction. Next, we demonstrated that CEP170 is a key factor 
for chlamydial control of MT assembly, a role not ascribed to this protein in non-
infected resting cells. CEP170 additionally influences inclusion morphogenesis, host 
cell shape and chlamydial infectivity. We show that endogenous IPAM and CEP170 
act together to promote MT assembly from the inclusion. Together, our data 
demonstrate the ability of a virulence effector to manipulate the microtubule 
network to support intracellular bacterial development. 
 
Results: 
 
IPAM- a Chlamydia inclusion protein acting on microtubules 
Using confocal microscopy, we initially confirmed the arrangement of the MT 
network during inclusion maturation in detail in HeLa cells (Fig 1A). At 12h, MTs 
assemble at the inclusion periphery, and filaments partially cover this early structure. 
By 24 h, MTs have entirely surrounded the inclusion from where some filaments 
extend and contact the plasma membrane. Later (48-66 h), a dense MT scaffold 
encircles the inclusion. This scaffold is associated with a ‘nest’ of MTs that originate 
at the inclusion and extend towards the plasma membrane. The scaffold and nest 
MT superstructure was even more evident when human osteosarcoma cells (U2OS) 
were infected with C.trachomatis (Fig 1B; Nans et al., 2014). Indeed, these cells have 
a larger cell volume and consequently a cytoskeleton easier to observe in 
comparison to HeLa cells. In particular, it was easier to discern at later timepoints 
(48-66 h) that MT actively accumulated around the inclusion periphery in the cell 
body rather than being compressed against the plasma membrane during inclusion 
expansion (compare Fig 1A and 1B 66h). The initial MT scaffold present at 24 hpi, 
formed independently of the previously reported actin filament (F-actin) cage (Fig 1C, 
24h), although inclusion-associated F-actin and MT structures became partially co-
incident at later time points (Fig 1C, 48h and 66h). Thus, host MTs are progressively 
organized at the inclusion surface and assemble into an interlinked scaffold and nest 
superstructure.  
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The proximity of MTs and the inclusion suggested that a chlamydial effector located 
in the inclusion membrane might influence this process. As Chlamydiae encode Incs, 
we investigated whether any of these proteins shared sequence homology with MT-
interacting proteins. Homology searches revealed that the predicted cytosol-
exposed C-terminal domain (CTD) encompassing residues 90-268 of Inc CT223 
shared significant primary sequence similarity with human MT and centrosome-
interacting proteins including pericentrin (Fig S1). In other Incs, similar interfaces 
enable host protein binding (Delevoye et al., 2008, Rzomp et al., 2006, Scidmore and 
Hackstadt, 2001). Provocatively, CT223 localizes to the inclusion membrane during 
infection (Bannantine et al., 2000), and the expression of CT223-CTD in cultured cells 
is correlated with cytokinesis defects (Alzhanov et al., 2009), a cellular process in 
which MT dynamics are key (D’Avino et al., 2005). We hereafter refer to CT223 as 
inclusion protein acting on microtubules (IPAM). 
Consequently, we initially investigated the localization of endogenous IPAM in cells 
infected with C.trachomatis, and any relationship to the host centrosome. We 
confirmed that IPAM was present at the inclusion membrane (Bannantine et al., 
2000), throughout the infection timecourse (Fig 1D). Strikingly, IPAM predominantly 
accumulated in defined patches at the inclusion periphery that frequently coincided 
with or were closely apposed to the centrosomes (Fig 1D, 1E and Fig S2A). 
Centrosome supernumeracy was also evident (Fig 1D; Johnson et al., 2009). 
Given that endogenous IPAM patches are located at the inclusion periphery in 
proximity to the centrosome, we next investigated the effects of IPAM on the 
centrosome and MT organization in the absence of infection. We transiently 
expressed IPAM90-268 as a GFP fusion in cultured cells. GFP-IPAM90-268 localized with 
centrosomal proteins -tubulin and pericentrin (representative images in Fig 2A), 
showing that IPAM is sufficient to associate with the centrosome, and therefore with 
the principal microtubule organizing center (MTOC) of the cell. Super-resolution 
structural illumination microscopy (SIM) revealed that GFP-IPAM90-268 is in close 
apposition to -tubulin and pericentrin, rather than co-localized, suggesting IPAM90-
268 association with the pericentriolar matrix (PCM) and/or MT minus-ends (Fig 2B). 
Moreover, GFP-IPAM90-268 expression induced centrosomal abnormalities including 
supernumeracy of -tubulin and pericentrin puncta and even the loss of defined 
Jo
ur
na
l o
f C
el
l S
ci
en
ce
A
cc
ep
te
d 
m
an
us
cr
ip
t
centrosomes in some cells (Fig 2C and Fig S2B). The most pronounced effect was on 
pericentrin distribution (Fig 2D). Altogether, these data demonstrate that IPAM90-268 
targets and destabilizes the host PCM.  
As the main function of the MTOC is to assemble and organize MT, we observed the 
MT network in cells transfected with IPAM90-268. At low expression levels, GFP-
IPAM90-268 is located exclusively at the center of the MT array, which appeared 
structurally indistinguishable from that in control cells (Fig 2E). However, increased 
GFP-IPAM90-268 expression provoked some MT disorder but did not affect F-actin 
architecture at steady state (Fig 2E and Fig S3A). In dividing cells, GFP-IPAM90-268 
localized to the spindle pole and apparently partitioned preferentially to one 
centriole (Fig 2F). This mobility confirmed the strong affinity of GFP-IPAM90-268 for 
the centrosome, which is retained even during physiological remodeling of the MT, 
and suggests that ectopically expressed IPAM90-268 is unlikely to be forming inactive 
cytosolic aggregates. 
Given the effect of IPAM90-268 on the PCM and the robust relationship between the 
pericentriolar material and MT organization (Woodruff et al., 2014), we analyzed the 
impact of IPAM expression on MT assembly following MT depolymerization and 
regrowth. GFP-IPAM90-268 localization remained unchanged after MT disassembly (Fig 
S3B), indicating MT-independent association of IPAM90-268 with the centrosome. 
Moreover, the presence of GFP-IPAM90-268 did not interfere with MT 
depolymerisation upon induced disassembly (Fig S3C). After 5 min regrowth, GFP-
IPAM90-268 remained enriched at the centrosome, and additional GFP-IPAM90-268 foci 
were observed along newly polymerized MTs (Fig 2G). Higher levels of expressed 
GFP-IPAM90-268 generated multiple MT nucleation foci within individual cells (Fig 2G). 
Nucleated MTs were non-homogenous in length and appeared to form a randomly 
oriented network. When examined at higher resolution by SIM, it was evident that 
even low-level GFP-IPAM90-268 expression was sufficient to alter nucleation foci and 
generated shorter and interconnected emergent MT networks in comparison to 
those in GFP-control cells (Fig 2H). Multi-foci MT networks were apparent in 
62.9±1.2% of GFP-IPAM90-268 transfectants versus 11.1±1.6% of GFP-control cells (Fig 
2I). Thus, IPAM-CTD perturbs MT organization and assembly. 
Therefore, we demonstrate that IPAM-CTD, which shares homology with eukaryotic 
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centrosomal and MT-related proteins, targets the main cellular MTOC and 
destabilizes the PCM. Consequently, the microtubule organizing activity of the MTOC 
is disturbed, even when IPAM-CTD is expressed at low levels. Furthermore, when 
IPAM90-268 is overexpressed, ectopic MT nucleation foci are formed. Together, these 
data show that IPAM associates with the PCM at the centrosome and is sufficient to 
hijack the microtubule organizing function of the host cell.  
Chlamydia IPAM interacts with host CEP170 to perturb MT assembly 
To identify eukaryotic interacting partners using a pull-down approach, we 
expressed IPAM in Escherichia coli. Full-length hydrophobic IPAM partitioned 
predominantly to the bacterial membrane fraction (Fig 3), from where it could only 
be solubilized with detergent, indicating insertion of IPAM into the E.coli membrane. 
Further purification was carried out under native conditions (Fig 3; see Materials and 
Methods). Exploiting the affinity tag, we performed a pull-down assay using purified 
IPAM and human cell extract (see Materials and Methods), and identified twelve 
candidate interacting proteins by mass spectrometry. Of these, six were MT and 
centrosome related, the most significant being centrosomal protein 170 (CEP170; 
Mascot score 65.56, 2 peptides read 10 times each). CEP170 is a component of the 
mother centriole that interacts with kinesin-like motors during cell division (Maliga 
et al., 2013; Welburn and Cheeseman, 2012; Guarguaglini et al., 2005). Furthermore, 
CEP170 overexpression disturbs centrosomal positioning and the MT network 
(Guarguaglini et al., 2005). Given the similar effects of IPAM-CTD expression on the 
centrosome and MTs (Fig 2) we focused on examining potential interplay between 
IPAM and CEP170 during C.trachomatis inclusion biogenesis. 
GFP-IPAM90-268 was co-isolated following immunoprecipitation of CEP170 from 
transfected cells (Fig 4A). Reciprocally, endogenous CEP170 was co-purified when 
GFP-IPAM90-268 was immunoprecipitated from transfectants (Fig 4A). Thus, the IPAM-
CTD is sufficient for CEP170 interaction in cells. Immunostaining of endogenous 
CEP170 in GFP-IPAM90-268 transfectants demonstrated co-localization of both 
proteins at the centrosome (Fig 4B), consistent with our in vitro association data.  
Next, we investigated whether CEP170 is required for centrosomal localization of 
IPAM90-268. CEP170 knockdown was confirmed by immunofluorescence and 
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immunoblotting (Fig S3D and Fig S3E). Silencing of CEP170, did not release GFP-
IPAM90-268 from the centrosome, and -tubulin and pericentrin localization remained 
similarly undisturbed (Fig 4C), in agreement with previous observations 
(Guarguaglini et al., 2005). Nevertheless, higher levels of GFP-IPAM90-268 expression 
promoted CEP170 redistribution into additional extra-centrosomal foci, where both 
proteins co-localized (Fig 4D and E). While CEP170 is therefore not necessary for the 
association of GFP-IPAM90-268 with the centrosome, GFP-IPAM90-268 expression is 
sufficient to influence CEP170 localization in cells.  
Given this dynamic interplay between GFP-IPAM90-268 and CEP170, we determined 
whether CEP170 was required for GFP-IPAM90-268-mediated disruption of the 
centrosome. We examined -tubulin and pericentrin in cells expressing control-
siRNA or CEP170 siRNA in the presence or absence of GFP-IPAM90-268, and classified 
the resultant centrosomal structures (Fig S2B). The nature of the defects particularly 
in the PCM reported by pericentrin was subtly yet significantly altered when cells 
received CEP170-siRNA (Fig 4F and 4G), demonstrating a partial role for CEP170 in 
IPAM-mediated PCM interference. Similarly, we investigated whether CEP170 was 
necessary for IPAM90-268 to disturb MT organization (Fig 4H). CEP170 knockdown did 
not influence the MT organization in GFP-control cells but partially rescues GFP-
IPAM90-268-induced defects in MT assembly, restoring MT regrowth (Fig 4H). 
Additionally, the normal MT organization during regrowth in CEP170-siRNA cells (i.e. 
in the absence of GFP-IPAM90-268) strongly suggests that CEP170 does not play a 
housekeeping role in MTOC function per se.  Consequently, we conclude that the 
interaction between IPAM90-268 and CEP170 is functional. 
Taken together, we show that IPAM interacts with the host protein CEP170. While 
IPAM90-268 localization to the centrosome is CEP170-independent, the effect of 
IPAM90-268 on PCM and the MT organization is mainly CEP170-dependent.  
 
CEP170 influences MT organization via IPAM in infected cells  
As IPAM is sufficient for CEP170 interaction, we next examined the relative location 
of endogenous IPAM and CEP170 in cultured HeLa and U2OS cells infected with 
C.trachomatis. CEP170 was present in patches at the inclusion membrane from 24 
hpi and multiple patches were evident at 66hpi (Fig 5). Consistent with the in vitro 
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interaction and the effects of IPAM90-268 in cultured cells, co-localization between 
IPAM and CEP170 was observed at the inclusion, although as might be expected 
during infection, both IPAM and CEP170 were additionally present in isolation (Fig 5). 
Since CEP170 influences MT organization only in the presence of IPAM, we 
investigated the effect of silencing CEP170 expression on MT organization during 
inclusion biogenesis. CEP170 knockdown remained stable for the duration of the 
infection cycle (Fig S3D and S3E), and did not significantly influence the early phase 
(<24 h) of bacterial development in cultured cells (Fig S3F). Although Nigg and co-
workers suggested that CEP170 knockdown in HeLa cells induced a change in cell 
shape from a cobblestone to elongated phenotype (Guarguaglini et al., 2005), under 
our growth conditions, non-infected HeLa cells remained elongated independently of 
CEP170 knockdown (Fig 6A). Nevertheless, after infection with C.trachomatis, 
simultaneous CEP170 knockdown resulted in rounding of the infected cells whereas 
infected control-siRNA cells remained elongated at both 48 h and 66 h (Fig 6A, Fig 
S2E and Fig S4A). This indicated a significant CEP170-dependent change in host 
cytoskeletal organization in infected cells. To investigate this, we visualized the MT 
network in these two cell populations. In the infected control cells, the MT network 
displayed a radial organization where MTs emerge from the CEP170-positive MTOC 
to form the characteristic MT scaffold and nest. In equivalently infected CEP170 
knockdown cells, there were profound alterations; a partial MT scaffold was formed 
by an array of parallel MTs without a distinct point of emergence, and the MT nest 
was absent, driving the distinct rounded cell phenotype (Fig 6B and Fig S4A). 
Nevertheless, the extent of co-localization between F-actin and the MT network 
surrounding the aberrant-shaped inclusion was not significantly affected in infected 
CEP170-siRNA cells (Fig S3G). Intriguingly in non-infected cells, the MT and F-actin 
networks in CEP170 knockdown cells were indistinguishable from controls at steady 
state (Fig S3H), correlating with the absence of a change in cell shape in these two 
populations (Fig 6A). This strongly suggests that the CEP170-dependent pathway 
stimulated by C.trachomatis to reorganize MTs is silent in resting uninfected cells or 
unconventional in infected cells. 
To probe further how CEP170 functions relate to IPAM, we examined the 
consequences of GFP-IPAM90-268 overexpression in infected cells in the presence and 
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absence of CEP170. When expressed in infected cells, GFP-IPAM90-268 puncta are 
enriched at the inclusion, with a minor population present at the cell periphery (Fig 
6C). Moreover, we observed a more prominent MT scaffold associates with a hyper-
developed nest, modifying the cell shape in a distinctive manner in cell expressing 
endogenous levels of CEP170 (Fig 6C and 6D). This exaggerated phenotype due to 
the presence of high levels of GFP-IPAM90-268 in infected cells is indicative of an 
IPAM-induced overstimulation rather than a dominant negative effect. In CEP170-
siRNA cells, GFP-IPAM90-268 overexpression partially reverts the defect in the 
formation of the MT nest (Fig 6D), suggesting that GFP-IPAM90-268 is able to 
compensate for loss of CEP170 via a secondary or redundant pathway.  
These data reinforce our view that CEP170 function is extended in infected cells, and 
that this augmentation depends on IPAM90-268. Also, while IPAM90-268 preferentially 
acts with CEP170 to organize MTs, as with other bacterial effectors IPAM can also 
stimulate redundant pathways, possibly via additional interacting partners, to 
reorganize MTs in the absence of CEP170. 
 
CEP170 is essential for MT assembly, inclusion morphology and Chlamydia 
replication.  
Given that CEP170 is a key determinant of MT organization during infection, we next 
examined MT regrowth to assess the dynamics of this mechanism (Fig 7). CEP170 
knockdown does not significantly influence MT regrowth in non-infected cells (Fig 
S3I and S2D). In infected cells, newly polymerized MTs emerged from single or 
multiple MTOC and encased the inclusion after 5 min. After 20 min, MT 
accumulation around the inclusion was less pronounced than at steady state but the 
nest did reform (Fig 7). After CEP170 knockdown, MTs emerged from an enlarged 
structure following 5 min regrowth at 48 h, and at 66 h tubulin dramatically 
accumulated at one pole of the inclusion under equivalent conditions (Fig 7) 
demonstrating the critical role for CEP170 in MT assembly. After 20 min regrowth, 
MTs are present as in control cells, but inclusions lost their typical spherical 
morphology and appear constricted (Fig 7). Indeed, inclusion architecture was 
severely disrupted, as voids, characterized by the absence of bacteria and MTs in the 
presence of an intact inclusion membrane were evident (Fig 7 and S4B). This is 
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interesting as it was predicted using experiment-based mathematical models that 
contact between the bacteria and the inclusion membrane controls chlamydial 
development (Wilson et al. 2006, Hoare et al. 2008). Consequently, we investigated 
whether CEP170 is required for chlamydial infectivity. Although siRNA-mediated 
knockdown inherently generates a mixed population of cells expressing varying 
levels of CEP170, CEP170 knockdown significantly attenuated the infectivity of 
C.trachomatis progeny (12.3x104± 2.7x104 in control-siRNA versus 6.3x104± 2.3x104 
in CEP170-siRNA).  
These data demonstrate a key role for CEP170 in MT assembly at the inclusion 
periphery allowing the maintenance of inclusion shape and the success of the 
chlamydial infectious cycle. 
 
The endogenous IPAM-CEP170 interaction is involved in MT assembly in 
C.trachomatis infected cells. 
Using transfected cells and knockdown approaches, we demonstrate that the IPAM-
CTD perturbs MT assembly via its interaction with CEP170, which is essential for MT 
organization in infected cells. Next, we investigated the nature of the MT nucleation 
centers in infected cells, examining endogenous IPAM and CEP170. In order to 
facilitate the observation of the point of emergence of MTs, we performed a MT 
regrowth assay for 5 min. At 48 hpi, 75% of infected cells showed multiple points of 
MT nucleation on the inclusion, which are ubiquitously observed by 66hpi in both 
HeLa and U2OS cells (Fig 8A and Fig 8B). Interestingly, these MTOCs are distributed 
across the 3D volume of the inclusions either individually or as groups (Fig 8A and Fig 
8B, insets showing different z positions).  
In both cell lines, ~95% of inclusion-associated MT nucleation foci contained CEP170 
in defined points or more diffusely. Occasionally, patches of co-localized IPAM and 
CEP170 are observed without emerging MTs, although 50% and 60% of the CEP170-
positive MT nucleation foci localize with IPAM patches in HeLa and U2OS cells, 
respectively (Fig 8A and Fig 8B) indicating the presence of the IPAM-CEP170 complex 
in at least half of inclusion-associated MT nucleation centers captured by this 
method in infected cells. 
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These data reveal that endogenous IPAM and CEP170 cooperate at the surface of 
the inclusion to orchestrate host MT reorganization. 
 
Discussion:  
We demonstrate that Chlamydia trachomatis integrates a transmembrane effector, 
IPAM, into the inclusion membrane to locally hijack host MT organizing activity by 
recruiting CEP170. We propose that this event leads to the formation of a MT 
‘scaffold and nest’ superstructure necessary to maintain cell and inclusion 
morphology, which is consequently required for bacterial infectivity. Moreover, we 
show that CEP170 exhibits additional roles in MT organization when compared to 
resting cells. 
IPAM shares sequence similarity with MT and centrosomal proteins. We confirmed 
that the C.trachomatis inclusion traffics to and associates with the MTOC (Richards 
et al., 2013; Grieshaber et al., 2006) and demonstrated the proximity of endogenous 
IPAM patches and the centrosome. When IPAM-CTD is expressed in cells, it localizes 
to the centrosome, the principal MTOC. IPAM90-268 induces centrosomal 
abnormalities with a pronounced effect on the organization of the PCM. This is 
intriguing considering that centrosomal dysfunction is correlated to aneuploidy and 
tumor initiation (Nigg, 2002) and that C.trachomatis infection is associated with 
cervical cancer (Smith et al., 2004; Koskela et al., 2000).  
Consequently, the MTOC is able to generate MTs, but their organization is disrupted. 
When IPAM90-268 is overexpressed, multiple MT nucleation centers become evident. 
These data show that IPAM is sufficient to reprogram the MT organizing activity of 
the host cell. Intriguingly, in C.trachomatis infected cells, multiple MTOC are 
observed and we demonstrated that 50-60% of the CEP170-positive MT nucleation 
foci were associated with IPAM. 
While IPAM90-268 localization to the centrosome is CEP170 independent, IPAM-
directed PCM disruption and MT reorganization is largely dependent on CEP170. This 
demonstrates functional interaction between IPAM90-268 and CEP170, and reveals 
CEP170 activities not previously observed in resting non-infected cells. These 
extended functions were supported by CEP170 knockdown. In our hands, non-
infected cells lacking CEP170 exhibited no detectable abnormalities in cell shape, MT 
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organization or MT assembly. By contrast, knockdown of CEP170 in C.trachomatis 
infected cells resulted in a reduced MT scaffold and the absence of the MT nest, 
leading to a characteristic round cell shape. This was accompanied by defects in MT 
organization during regrowth and changes in inclusion morphology. Thus, CEP170 
functions are exacerbated during C.trachomatis infection. Indeed, these additional 
functions highlighted by studying infection could indicate dormant or incompletely 
understood roles for CEP170 in non-infected non-dividing cells. Intriguingly, 
overexpression of IPAM90-268 in infected cells can maintain MT architecture in the 
absence of CEP170, showing that IPAM can functionally compensate using CEP170-
independent secondary or redundant pathways possibly by interacting with 
additional eukaryotic binding partners. 
Our data therefore show that IPAM reorganizes MT indirectly by interacting with 
CEP170 and possibly other eukaryotic partners. This is distinct from other bacterial 
effectors including Chlamydia trachomatis CopN, which act directly on tubulin 
subunits to inhibit polymerization (Archuleta et al., 2011). To our knowledge, this is 
the first example of such significant structural changes in organization of the MT 
network by an intracellular bacterial pathogen. Salmonella, Brucella and Legionella 
all exploit the MT network to commandeer vesicular transport, but the associated 
MT architecture is not profoundly rearranged (Radhakrishman and Splitter, 2012). 
Only a toxin secreted by the extracellular bacterium Clostridium generates localized 
MT reorganization by inducing MT-derived protrusions (Schwan et al., 2009).  
Recently, a population of specialized post-translationally modified MTs was observed 
surrounding the inclusion, which is required for Rho-dependent tethering of Golgi 
mini-stacks. It was proposed that C.trachomatis must initially reorganize MTs that 
are subsequently detyrosinated 2 to 3 hours later (Al-Zeer et al., 2014). As the 
inclusion expands over time, these specialized MTs must be continuously readjusted 
by a cycle of MT assembly and modification, as also suggested for the actin cage 
(Kumar and Valdivia, 2008). Our data mechanistically complement and extend this 
study, as we identify IPAM that initiates MT organization at the inclusion surface by 
recruiting CEP170. Subsequently, these MTs could be modified by unknown host or 
additional chlamydial factors, allowing Rho-dependent organelle positioning. 
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CEP170 binds MT (Guarguaglini et al., 2005), but whether IPAM also engages MT 
directly or requires CEP170 remains unknown. Moreover, as Incs have the propensity 
to engage each other in heterotypic Inc-Inc complexes (Gauliard et al. 2015), 
additional Incs might interact with IPAM at the inclusion membrane and could 
regulate its activity. For instance, recent evidence suggests that the Inc CT850 binds 
the MT-associated motor protein dynein (Mital et al. 2015). Moreover, it is known 
that CEP170 is phosphorylated by Polo-like kinase 1 (Guarguaglini et al., 2005). How 
the phosphorylation of CEP170 is involved in the formation or activities of the IPAM-
CEP170 complex or influence chlamydial infection remains unknown. Further in vitro 
reconstitution experiments are now essential to understand the molecular 
mechanisms of IPAM- and CEP170-mediated MT and centrosomal subversion in 
detail, and to delineate the domains of each partner involved in their functional 
interactions. 
 
Materials and Methods: 
 
Sequence homology searches 
The primary amino acid sequences of the 55 predicted inclusion proteins from 
C.trachomatis serovar L2 (Lutter et al., 2012) were compared to the Homo sapiens 
(taxid 9606) database using Blast (blast.ncbi.nlm.nih.gov/Blast.cgi). Results were 
manually filtered for known MT/centrosomal proteins, and ranked according to the 
number of identical/similar amino acid residues. 
 
Cell culture, transfection, knock down and infection 
HeLa or U2OS cells were routinely cultured in DMEM containing 10% (v/v) fetal calf 
serum and antibiotics [penicillin (100 Uml-1)/streptomycin (100 gml-1) or gentamicin 
(25 gml-1), Invitrogen].  
Cells were transfected with pEGFP-C2 or pEGFP-IPAM90-268 (300 ngml-1), using 
Turbofect according to the manufacturer’s instructions (Fermentas).  
Cells were transfected with 10 nM of siRNA designed against CEP170 sequence or 
against non-specific sequence, using Hiperfect according to the manufacturer’s 
instructions (Qiagen). Three siRNAs (5’-AAGCATGGAGATTTCTTCTAT-3’, 5’-
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AAAGTGTTTCTGGAACTTTAA-3’, 5’-TTGGATATGATACAAATCTTT-3’) directed against 
CEP170 were independently validated by Western blot and immunofluorescence.  
Cells were infected with C.trachomatis serovar L2 as previously described (Dumoux 
et al. 2012). 
When these approaches were used in combination, cells (density 4x104 cm-2 plated 
24 h previously) were transfected with plasmids immediately prior to infection (i.e. 
t=0h), or with siRNA 24 h prior to infection. When appropriate, expression plasmids 
were transfected 48 h after transfection of siRNA. 
 
Infectivity assay 
Bacterial infectivity was tested as previously described (Dumoux et al., 2012). 
 
Microtubule regrowth assay 
At an appropriate time point, cells were treated with 10ngml-1 nocodazole (Sigma-
Aldrich) for 4 h at 37oC. Steady state cells were directly fixed and stained. “0min” 
samples were fixed and stained directly after incubation at 4oC for 20 min, whereas 5 
min or 20 min samples were appropriately incubated further at 37oC in nocodazole- 
free media prior to fixation and immunolabelling. 
 
Cell Labeling 
 For immunolabelling, cells were fixed with either cold methanol (5 min on ice) or 4% 
(w/v) parafolmaldehyde in cytoskeleton buffer with sucrose (CBS, 10 mM MES, 138 
mM KCL, 3 mM MgCl, 2 mM EGTA and 0.32 M sucrose; 30 min, RT), and 
permeabilized with cold methanol/ethanol or 0.5% (v/v) Triton-X100 in CB. Primary 
antibodies, anti-IPAM (generous gift from Dan Rockey), anti-CEP170 (Invitrogen), 
anti-IPAM, anti-α/β-tubulin (Cytoskeleton), anti- β-tubulin (Millipore), anti--tubulin 
(Abcam) or anti-pericentrin (Covance), were diluted in PBS containing 1% (w/v) 
bovine serum albumin (BSA) and incubated (3h, RT) prior to incubation with 
appropriate secondary antibodies (Invitrogen) in the same buffer (1h30, RT). 
Samples were mounted using Mowiol. 200nM Rhodamine-coupled phalloidin 
(Invitrogen) was added to the primary antibody mixture. WGA AlexaFluor 594 
labeling (45 min, RT) was performed prior to cell permeabilisation. For simultaneous 
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labeling of IPAM, β-tubulin and CEP170, primary antibodies were appropriately 
diluted in PBS containing 10% (w/v) BSA and secondary antibodies coupled to 
AlexaFluor 488, 546 or 633 were selective for mouse IgG subclasses. Controls to 
exclude cross-reactivity were performed prior to the infection experiments. 
 
Microscopy 
Samples were observed using a confocal microscope (TCS Sp5 or Sp8 AOBS; Leica) 
with an oil-immersion objective (63x, 1.4 NA; Leica) operated in sequential mode. 
Using the AOBS, emission windows were selected to ensure no leak between 
channels using equivalent samples labeled with a single fluorophore. Laser 
reflections were avoided by allowing a distance of at least 10 nm between the laser 
used for excitation and the start of the corresponding emission window. Optical z-
sections were collected every 330nm. 
An OMX V3 (API, division of GE Healthcare) was used for super-resolution 
microscopy. For this technique, coverslips (Zeiss) were mounted using Vectashield 
instead of Mowiol, and viewed using an oil-immersion objective (100x, 1.4 NA; 
Olympus). Prior to acquisition, the OTF for each channel were calculated using 
calibration beads, the color channels aligned, and CCD camera noise corrected. 
Image acquisition and reconstruction was performed using DeltaVision software.  
 
Image analysis, 3D reconstruction and quantification 
All images were analyzed using Fiji (Eliceiri et al., 2012). Greyscale modifications 
were applied across all conditions, and thresholds remained constant. Maximum 
intensity projections (max-projection) of a few z-stacks are required to observe the 
entire MTOC.  
The 3D viewer plugin (Schmid et al., 2010) was used for 3D-reconstruction, and the 
volume displayed as a surface using a constant threshold. Prior to 3D-reconstruction, 
images were treated using the rolling-ball-background algorithm plugin with a mean 
filter of 1.5 pixels.  
To determine the level of expression, puncta of GFP-IPAM90-268 were scored from a 
maximum projection of the entire volume of the cell. Cells with 10 or less puncta 
were considered as cells expressing low levels of GFP-IPAM90-268. For cells expressing 
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GFP, cells with mean pixel intensity <33% of the maximum grey value were 
considered as low expressing cells.  
When quantification was performed, approximately 150 infected cells and 250 non-
infected cells per condition were analyzed. Representative images of the different 
classifications used are shown in Fig S2. Student’s t-test was applied for statistical 
analyses. 
Centrosome positioning and IPAM patches (Fig S2A): a mask of the inclusion was 
generated as described (Dumoux et al., 2012) without the ‘fill hole’ option. The 
inclusion periphery was detected using the ‘find edges’ option (yellow line) and the 
outline superimposed back onto the RGB images. Centrosomes (-tubulin) in contact 
with the inclusion periphery were scored manually. 
Centrosomal markers (Fig S2B): cells (15±7) within fields of view were imaged and 
max-projection applied to the entire z-stack. After manually tracing cell edges, the 
number, position and appearance of centrosomal labelling was categorized 
according to the classification presented in Fig S2B.  
MT regrowth, low magnification (Fig S2C): cells (15±7) within fields of view were 
imaged and max-projection applied to the entire z-stack. After manually tracing cell 
edges, the number of MT regrowth foci were quantified according to the criteria 
presented in Fig S2C. 
MT regrowth, high magnification (Fig S2D): in cases where >97% of the cells 
exhibited mono-foci according to the criteria presented in FigS2C, cells within fields 
of view (9±3.5) were imaged at higher magnification, and max-projection applied to 
the entire z-stack. After manually tracing cell edges, MT regrowth foci were assessed 
manually according to the criteria presented in Fig S2D. 
Cell shape (Fig S2E): cells (15±7) within fields of view were imaged and max-
projection applied to the entire z-stack. Confluent cells were excluded. After 
manually tracing cell edges, the number of round or elongated cells were quantified 
according to the criteria presented in Fig S2E.  
Inclusion shape (Fig S2F): DNA was stained and cells (9±3.5) within fields of view 
imaged. Inverted LUT and grey scale modifications were performed uniformly. 
Manual quantification was performed according to the criteria presented in Fig S2F. 
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Plasmids 
pET22b-IPAM was generated by polymerase chain reaction (PCR) amplification of the 
gene encoding IPAM (CT223) from Chlamydia trachomatis serovar L2 genomic DNA. 
The PCR product, engineered to contain an NdeI restriction site at the 5’ of the start 
codon and a XhoI restriction site at the 3’ end of the gene, was cloned into the 
corresponding sites of the T7 expression vector pET22b (Novagen) creating an in-
frame C-terminal fusion of six histidine residues (expected size: 32kDa). 
pEGFP-IPAM90-268 encoding the cytoplasmic domain of IPAM (IPAM90-268) was 
generated by PCR amplification of the appropriate fragment of the IPAM (CT223) 
gene from Chlamydia trachomatis serovar L2 genomic DNA. The PCR product was 
engineered to generate an EcoRI restriction site followed by a start codon prior to 
the codon encoding residue 90 of IPAM and a KpnI restriction site at the 3’ of the 
stop codon. This was cloned into the corresponding sites of the expression vector 
pEGFP-C2 (Clonetech) creating an in-frame N-terminal fusion of green fluorescent 
protein (GFP) (expected size: 52kDa). 
 
Expression and purification of IPAM  
pET22b-IPAM E.coli C41(DE3) (Miroux and Walker, 1996) transformants were 
cultured (200 g, 37oC) in Luria’s broth (LB) containing ampicillin (50ugml-1) until 
A600~0.8. Protein expression was induced using 0.05 mM isopropyl β-D-
thiogalactopyranoside (IPTG, Sigma-Aldrich) and incubation continued (2h, 37oC). 
Cells were harvested (2000 g, 15 min, 4oC) and resuspended in Tris-buffered saline 
(20 mM Tris HCl pH7.4, 140 mM NaCl; TBS) containing protease inhibitors (Roche), 
prior to lysis with a pressure cell homogeniser (18000 psi, Stansted). After 
clarification (2000 g, 10 min, 4oC), membranes were separated by centrifugation 
(31000 g, 1h, 4oC). Membranes containing IPAM were incubated with appropriate 
buffers (TBS, or 20 mM Tris HCl pH7.4, 1 M NaCl; TBS, 100 mM Na2CO3 pH11; 8 M 
urea) or with 1% (w/v) detergent [ASB-14 (Millipore), Triton X-100 (Sigma-Aldrich), 
CHAPS (Sigma-Aldrich), dodecyl--d-maltoside (Sigma-Aldrich), polyoxyehltylene 
(Lane et al. 2008) tridecyl ether (Sigma-Aldrich), C7BZ0 (Sigma-Aldrich), octyl--d-
glucopyrone (Sigma-Aldrich) or octyl--d-1-thioglucopyrone (Sigma-Aldrich)] in TBS 
containing protease inhibitors (Roche). Solubilized material was recovered by 
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centrifugation (31000 g, 1 h, 4oC). 0.7% (w/v) ASB-14-containing buffer extracted 
IPAM from the membrane most effectively, and was retained during binding and 
then elution from nickel nitrilotriacetic acid-agarose, which was carried out under 
native conditions according to the manufacturer’s instructions (Qiagen).  
 
Pull down assay 
Purified IPAM was incubated (10 min, RT) with magnetic beads coupled to cobalt 
(Dynabeads, Invitrogen) before incubation (45 min, rotating, 30 oC) with HeLa cell 
lysate (106 cells sonicated 20 pulses, 5 sec, 18 V, 4oC; Misonix XL-1000 ultrasonicator) 
in phosphate buffer saline (PBS) containing 175 gml-1 phenylmethylsulfonide 
fluoride (PMSF), 5gml-1 lysosyme and 1 mini-complete protease inhibitor tablet. 
Beads were then washed and stored at -80 oC. 
 
Mass spectrometry 
Bead-coupled proteins were digested overnight at 37°C with sequencing grade 
trypsin (12.5 μgml-1; Promega) in 20μl 25 mM NH4HCO3. Digests were analyzed using 
a LTQ Velos Orbitrap (Thermo Fisher Scientific) coupled to a nano-LC Ultimate 3000 
RSLCnano system (Thermo Fisher Scientific). Peptides were analysed in the orbitrap 
in full ion scan mode at a resolution of 30000 (at m/z 400) and with a mass range of 
m/z 400-1800. MS/MS data were searched against the NCBInr Homo sapiens and the 
SwissProt Chlamydia trachomatis databases. False Discovery Rate (FDR) was 
calculated using the reversed database approach with a 1% filter for strict FDR and 
5% for relaxed FDR. 
The presence of IPAM was verified. The Mascott score was 2395.22 with 10 peptides 
read 2-20 times. A differential analysis was applied to identify targets, using GFP and 
additional Inc proteins as a reference, and a threshold of >30 was applied to the 
Mascott scores. 
 
Co-immunoprecipitation 
24 h post transfection, protein-G magnetic beads (Dynabeads, Invitrogen) were 
coupled with anti-CEP170 (Invitrogen) or anti-GFP (Invitrogen) antibodies prior to 
incubation (45 min, rotating, 30oC) with lysate from HeLa cells expressing GFP-
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IPAM90-268 or GFP. After washing with PBS, proteins were eluted using 75 mM Tris 
HCl pH 7.4, 0.5M EDTA, 0.05% SDS and mixed with the same volume of loading 
buffer [80 mM Tris HCl pH6.8, 20% (v/v) glycerol, 0.16% (w/v) SDS, 20% (v/v) -
mercaptoethanol, 3mg.ml-1 bromophenol blue]. 
 
Protein electrophoresis and Western blotting 
Proteins were analysed by SDS-PAGE using 14% (v/v) acrylamide gels (Prosieve, 
Lonza). For gel staining, Coomassie blue R250 staining was performed. For Western 
blotting, proteins were transferred overnight at 4oC. Nitrocellulose membranes were 
incubated (1 h) in TBS, 0.05% (v/v) Tween 20, 5% (w/v) skimmed milk (TBST-milk) 
before an overnight incubation at 4oC with primary antibody diluted in the same 
buffer. Primary antibodies were anti-GFP (Clontech), anti-CEP170 (Invitrogen), anti-
His (Invitrogen) or anti--tubulin (Sigma-Aldrich). Membranes were washed with 
TBST, incubated (1 h, RT) with appropriate secondary antibodies coupled to 
horseradish peroxidase (HRP, Invitrogen) in TBST-milk and finally wash in TBST. 
Chemiluminescence-based immunodetection of HRP was performed according to 
the manufacturer’s instructions (ECL, GE Healthcare). Films (GE Healthcare) were 
exposed, developed (Xograph) and scanned (Epson). 
For densitometry, the protein of interest (CEP170) and a loading control (-tubulin) 
were detected from the same membrane. The ‘gel analysis’ algorithm in Fiji (Eliceiri 
et al., 2012) was used. A double ratio was used to simultaneously correct for loading 
and to compare to the control:  
%reduction = (intensityCEP170/intensity-tubulin)siRNA/(intensityCEP170/intensity-tubulin)control J
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Figures 
 
Fig 1: Cytoskeletal organization and -tubulin positioning in cells infected with 
C.trachomatis. 
HeLa cells (A) or U2OS cells (B) were infected with C.trachomatis and incubated for 
12, 24, 48 and 66 h, prior to fixation and staining for α/β-tubulin (red) or DNA 
(grey/blue). Panels show maximum projection of 4 z-slices. In A the cell periphery 
and the inclusion are outlined in grey and yellow, respectively. Arrows indicate the 
MT scaffold. Scale bar: 5 m. (C) HeLa cells were infected with C.trachomatis and 
fixed after 24 h, 48 h or 66 h. Cells were stained for DNA (grey/blue), /-tubulin 
(green) and actin (red). Panels show maximum projections obtained from the 4 z-
sections shown. Scale bar: 10 m. (D) HeLa cells were infected with C.trachomatis 
and fixed after 24 h, 48 h or 66 h. Cells were stained for DNA (grey/blue), 
endogenous IPAM (green) and -tubulin (red). Patches of endogenous IPAM are 
visible at the inclusion membrane as described in Fig S2A. Asterisks indicate IPAM 
patches proximal -tubulin foci. Inset shows the indicated region in a different z-
section. Panels show maximum projection of 4 z-sections. Scale bar: 10 m. (E) 
Histogram shows quantification of the proximity of IPAM patches and the 
centrosome from confocal imaging (Fig S2A).  
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Fig 2: Impact of GFP-IPAM90-268 on MT organization, centrosome integrity and MT 
assembly. 
(A) HeLa cells expressing GFP-IPAM90-268 (green) were fixed and stained for -tubulin 
or pericentrin (red). Fluorescence panels show maximum projection of 3 confocal z-
sections spanning the centrosome. Scale bar: 5m. (B) 3D reconstructions from 
structural illumination microscopy (SIM). Scale bar: 2 m. (C) Representative images 
of HeLa cells expressing high levels of GFP-IPAM90-268 (green) were fixed and stained 
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for -tubulin (red, upper) or pericentrin (red, lower). Scale bars: 5 m. (D) Following 
confocal imaging, the features of the -tubulin (upper) or pericentrin (lower) labeling 
were categorized (as shown in Fig S2B) using cells expressing GFP, GFP-IPAM90-268 low 
or GFP-IPAM90-268 high. *:p<0.05, **:p<0.01, ***:p<0.005. (E) HeLa cells expressing 
low or high levels of GFP-IPAM90-268 (green) were fixed and stained for /-tubulin 
(red). Panels show maximum projection of the entire z-stack. Scale bar: 5 m. (F) 
HeLa cells were transfected with GFP-IPAM90-268 or GFP (green) and labeled for DNA 
(blue) and for /-tubulin (red). Panels show cells in division. Scale bar: 5 m. (G) 
MTs were depolymerized in HeLa cells expressing GFP-IPAM90-268 (green) and 
allowed to regrow for 5 min prior to fixation and staining for /-tubulin (red). 
Panels show maximum projection of 4 confocal z-sections. Cell periphery is outlined 
in white, and N indicates the nucleus. Scale bar: 5 m. (H) MTs were depolymerized 
in HeLa cells expressing GFP, GFP-IPAM90-268 low or GFP-IPAM90-268 high (green). Panels 
show SIM reconstructions of MTs allowed to regrow for 5 min prior to fixation and 
staining for /-tubulin (red). The control GFP signal is absent as diffuse signals 
cannot be visualized by SIM. Scale bar: 2 m. (I) Following confocal imaging, MT 
architecture in individual cells expressing GFP or GFP-IPAM90-268 was categorized (as 
shown in Fig S2C) after MT depolymerisation and 5min regrowth. *** p<0.005.  
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Fig 3: Native affinity purification of IPAM from E.coli. 
Immunoblots with anti-His6 antibody of SDS-PAGE separated fractions from E.coli 
transformants expressing IPAM. Cell lysates before (Nind) and after induction with 
IPTG (Ind) are shown together with pellet following low speed centrifugation to 
remove aggregated proteins and unlysed cells (agg), bacterial cytosol (cy) and 
membrane (mb) fractions. Membranes were incubated with buffers [20 mM Tris-Cl 
pH7.4 (Tris), 20 mM Tris-Cl pH7.4 140 mM NaCl (NaCl), 20 mM Tris-Cl pH7.4 1 M 
NaCl (Tris NaCl), 100 mM Na2CO3 pH11 (Na2CO3), 8 M urea (urea)] or detergents in 
TBS [1% ASB-14, Triton-X-100 (Tx-100), CHAPS, dodecylmaltoside (DDM), C13E10, 
C7BzO, OG and OTG] prior to centrifugation to separate solubilized proteins in the 
supernatant (S) from the membrane pellet (P). IPAM is present at the expected 
molecular weight (32kDa, arrow) and multimers IPAM are also evident (asterisk). 
Immunoblot and Coomassie-blue stained elution (E) are shown after affinity 
purification in 1% ASB-14. Molecular weight markers are shown in kDa (right).  
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Fig 4: Functional interaction between GFP-IPAM90-268 and CEP170. 
(A) Immunoblots (WB) with anti-CEP170 or anti-GFP antibodies of SDS-PAGE-
separated proteins immunoprecipitated (IP) with anti-CEP170 or anti-GFP. IPAM 
multimers are evident (see Fig 3). Positions of molecular weight markers (kDa) are 
indicated (right). (B) HeLa cells expressing low levels of GFP-IPAM90-268 (green) were 
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fixed and co-stained for -tubulin or pericentrin (magenta/grey) and CEP170 (red). 
Insets show CEP170 (red) and -tubulin or pericentrin (grey) labeling only. Scale bar: 
2 m. (C) HeLa cells treated with CEP170-siRNA and expressing GFP-IPAM90-268 
(green) were fixed and co-stained for -tubulin or pericentrin (magenta) and CEP170 
(red). Scale bar: 2 m. (D) HeLa cells expressing high levels of GFP-IPAM90-268 (green) 
were fixed and stained for CEP170 (red). Panels show maximum projections of 4 
confocal z-sections (left). Scale bar: 5 m. Insets show indicated region at higher 
magnification (right) broken down into individual z-sections (2-5). Scale bar: 2 m. 
(E) 3D reconstructions from structural illumination microscopy, demonstrating that 
GFP-IPAM90-268 co-localizes with CEP170. Scale bar: 2 m. (F) -tubulin (left) or 
pericentrin (right) labeling was categorized (as described in Fig S2B) in HeLa cells 
treated with CEP170-siRNA or control-siRNA expressing GFP or GFP-IPAM90-268 as 
indicated. *:p<0.05. (G) Quantification of the MT network (as described in Fig S2C) in 
HeLa cells treated with CEP170-siRNA or control-siRNA expressing GFP or GFP-
IPAM90-268 as indicated. **:p<0.01. 
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Fig 5: IPAM and CEP170 location in C.trachomatis infected cells. 
HeLa cells (A) or U2OS cells (B) were infected with C.trachomatis for 24 h, 48 h or 66 
h and labeled for DNA (grey/magenta), endogenous IPAM (green) and CEP170 (red). 
Asterisk indicates IPAM patches (as described in Fig S2A) in proximity of CEP170 dots. 
Arrows indicate diffuse CEP170 signal associated to IPAM. Scale bar: 10 m. 
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Fig 6: CEP170-IPAM interaction is essential to maintain cell shape and microtubule 
organization in Chlamydia-infected cells.  
(A) HeLa cells were treated with control-siRNA or CEP170-siRNA, and infected with 
C.trachomatis where appropriate. Cell shape was assessed and categorized after 48 
h or 66 h. Cells in mitosis identified by DNA staining were excluded. **:p<0.01, 
***:p<0.005. (B) HeLa cells treated with CEP170-siRNA or control-siRNA were 
infected with C.trachomatis and fixed after 48 h or 66 h. Cells were stained for DNA 
(grey), CEP170 (green) and α/β-tubulin (red). Panels show maximum projections of 4 
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z-sections. Scale bar: 10 m. (C) HeLa cells were treated with CEP170-siRNA or 
control-siRNA for 24 h, prior to infection with C.trachomatis and transfection with 
plasmid encoding GFP or GFP-IPAM90-268 (green). 48 or 66 h later cells were fixed and 
labeled for DNA (grey/blue) CEP170 (purple) and α/β-tubulin (red). Panels represent 
maximum projections of 4 z-sections in cells 48 h after infection, showing a 
representative ‘hyper scaffold-nest’. The cell periphery is outlined in grey. Scale bar: 
5 m. (D) Following confocal imaging, cells shape was categorized (as described in 
Fig S2E) for C.trachomatis infected cells. ***:p<0.005, **:p<0.01. 
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Fig 7: CEP170 knockdown impairs microtubule assembly in cells infected with 
C.trachomatis. 
HeLa cells were treated with CEP170-siRNA or control-siRNA and infected with 
C.trachomatis. After 48 h (upper panels) or 66 h (lower panels), MTs were 
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depolymerized then allowed to regrow for 5 or 20 min prior to fixation. Cells were 
stained for DNA (grey/magenta), CEP170 (green) and α/β-tubulin (red). Panels show 
maximum projections of 4 z-sections. Void (V) is marked within an aberrant inclusion. 
Scale bars: 10 m. Histograms show assessment of inclusion morphology (as 
described in Fig S2F) under the conditions indicated. ***:p<0.005, 
**:p<0.01,*:p<0.05. 
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 Fig 8: Endogenous IPAM localizes to sites of microtubule assembly in C.trachomatis 
infected cells. 
HeLa cells (A) or U2OS cells (B) were infected with C.trachomatis for 48 h or 66 h 
prior to MT regrowth for 5 min. Cells were fixed and labeled for endogenous IPAM 
(green), CEP170 (red) and -tubulin (grey). Upper panels show max-projections 
through the entire cell volume. Lower panels, show the max projection of the 
indicated z-section from the marked region of interest. Asterisks indicate the IPAM 
patches where MT regrow. Scale bar: 10 m.  
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